Laverock Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Apex Bldg, 6 St. Pancras Way, London, Gr...Website
www.laverocktx.comRevenue
$9.9 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Laverock Therapeutics
Laverock Therapeutics is pioneering programmable gene silencing with its proprietary GEiGS® platform, enabling precise and durable control of gene expression. Their technology is designed to power next-generation cell and gene therapies in oncology, regenerative medicine, and rare genetic diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Laverock Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Laverock Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Laverock Therapeutics has new funding data
Earning: See what the market has to say on Laverock Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Laverock Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Laverock Therapeutics
Product Launch: Get notified when Laverock Therapeutics launches new products
Laverock Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Laverock Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Laverock Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Laverock Therapeutics
Compare insights from companies similar to Laverock Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Laverock Therapeutics
$9.9M
11-50
Private
$41.5M
2021
N/A
Company Profile Activity
Activity Insights
Laverock Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Laverock Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Laverock Therapeutics.
Laverock Therapeutics financials insights
Gather financial insights about Laverock Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$14.1M
2025
Seed
$27.4M
Laverock Therapeutics Tech Stack
A closer look at the technologies used by Laverock Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Open Position
Open Position
Open Position
Open Position
Laverock Therapeutics News & Media
Laverock Therapeutics to Present New Data on Programmable, Tunable, Stable and Specific Gene Silencing Platform at ESGCT
STEVENAGE, United Kingdom, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announces it is to present new data on its innovative gene-silencing platform at the European Society of Gene & Cell Therapy (ESGCT) Conference in Rome 22-25 October.Laverock Therapeutics makes significant advances in its unique programmable gene silencing platform and announces pipeline focus on advanced therapies in oncology and genetic diseases
STEVENAGE, United Kingdom, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announces significant progress in the industrialisation and validation of its technology platform enabling broadening of its potential therapeutic application. Laverock also confirms in house focus on the development of a pipeline of programmable advanced therapies iLaverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule
STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announces its conference attendance programme for the remainder of 2024.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Laverock Therapeutics
Sign Up For FreeTo access detailed company insights
Laverock Therapeutics is pioneering programmable gene silencing with its proprietary GEiGS® platform, enabling precise and durable control of gene expression. Their technology is designed to power next-generation cell and gene therapies in oncology, regenerative medicine, and rare genetic diseases.... Read More
